Author

Phillip E. Korenblat

Observed names: P Korenblat, P. E. Korenblat, P. Korenblat, P.E. Korenblat, PHILLIP E. KORENBLAT, Phillip E Korenblat, Phillip Korenblat, PhillipE. Korenblat

Observed institutions: Barnes-Jewish Hospital, Washington University in St. Louis, University Hospitals of Cleveland, University of Chicago, Barnes-Jewish West County Hospital, Royal Brompton Hospital, University Hospitals Cleveland Medical Center, Washington University Medical Center, Scripps Clinic

OpenAlex ID: A5024466535

Lebrikizumab Treatment in Adults with Asthma

2011 · Jonathan Corren, Robert F. Lemanske, et al. · New England Journal of Medicine · 1,524

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

2016 · Nicola A Hanania, Phillip Korenblat, et al. · The Lancet Respiratory Medicine · 469

The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease

2007 · Stephen I. Rennard, Charles Fogarty, et al. · American Journal of Respiratory and Critical Care Medicine · 439

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

2015 · Nicola A Hanania, Michael Noonan, et al. · Thorax · 381

Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids

2013 · Michael Noonan, Phillip Korenblat, et al. · Journal of Allergy and Clinical Immunology · 171

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

2023 · Andrew Menzies-Gow, Michael E Wechsler, et al. · The Lancet Respiratory Medicine · 162

PDF

Immune responses of human adults after oral and parenteral exposure to bovine serum albumin

1968 · Phillip E. Korenblat, Richard M. Rothberg, et al. · Journal of Allergy · 137

Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency

2003 · Chaim M Roifman, Harry Schroeder, et al. · International Immunopharmacology · 121

A Retrospective Study of Epinephrine Administration for Anaphylaxis: How Many Doses Are Needed?

1999 · Phillip Korenblat, Mark J. Lundie, et al. · Allergy and Asthma Proceedings · 118

Zafirlukast Treatment for Acute Asthma

2004 · Robert A. Silverman, Richard M. Nowak, et al. · CHEST Journal · 87

Systemic Mastocytosis Presenting as Osteoporosis: A Clinical and Histomorphometric Study

1991 · ARKADI CHINES, ROBERTO PACIFICI, et al. · The Journal of Clinical Endocrinology & Metabolism · 68

Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis

1998 · Ramón Vargas, Robert J. Dockhorn, et al. · Journal of Allergy and Clinical Immunology · 65

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma

2007 · Jonathan Corren, Phillip E. Korenblat, et al. · Clinical Therapeutics · 62

Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes

2014 · Andrew L. Kau, Phillip E. Korenblat · Current Opinion in Allergy and Clinical Immunology · 55

Effect of age on response to zafirlukast in patients with asthma in the Accolate clinical experience and pharmacoepidemiology trial (ACCEPT)

2000 · Phillip E Korenblat, James P Kemp, et al. · Annals of Allergy Asthma & Immunology · 51

The role of antileukotrienes in the treatment of asthma

2001 · Phillip E. Korenblat · Annals of Allergy Asthma & Immunology · 32

Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients

2014 · Mark T. Dransfield, Gregory Feldman, et al. · Respiratory Medicine · 30

PDF

24-hour bronchodilator efficacy of single doses of indacaterol in patients with persistent asthma: comparison with placebo and formoterol

2009 · Craig LaForce, Phillip Korenblat, et al. · Current Medical Research and Opinion · 30

Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population

2024 · Jonathan Corren, Stanley J. Szefler, et al. · The Journal of Allergy and Clinical Immunology In Practice · 26

PDF

Systemic mastocytosis and osteoporosis

1993 · A. Chines, R. Pacifici, et al. · Osteoporosis International · 26

Ipratropium Bromide Nasal Spray 0.03% Provides Additional Relief from Rhinorrhea When Combined With Terfenadine in Perennial Rhinitis Patients; A Randomized, Double-Blind, Active-Controlled Trial

1998 · Albert F. Finn, Donald Aaronson, et al. · American Journal of Rhinology · 24

Efficacy and Safety of Lebrikizumab in Severe Uncontrolled Asthma: Results from the Lute and Verse Phase II Randomized, Double-Blind, Placebo-Controlled Trials

2014 · Nicola A. Hanania, Michael J. Noonan, et al. · Journal of Allergy and Clinical Immunology · 21

PDF

Hypersensitivity reaction to desipramine

1987 · James R. Panuska, Thomas R. King, et al. · Journal of Allergy and Clinical Immunology · 21

Limited Coronal CT: An Alternative Screening Examination for Sinonasal Inflammatory Disease

1995 · Franz J. Wippold, Robert G. Levitt, et al. · Allergy and Asthma Proceedings · 20

Comparative Clinical Study of Inhaled Beclomethasone Dipropionate and Triamcinolone Acetonide in Persistent Asthma

1998 · Edwin Bronsky, Phillip Korenblat, et al. · Annals of Allergy Asthma & Immunology · 18

Works count: 68

Citation count: 4,301

H-index: 21

I10-index: 30